ScholarIQanswers from OpenAlex
Berry & Associates (United States)
InstitutionResearch output, impact & collaborations
Berry & Associates (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Berry & Associates (United States)?
ScholarIQrecord summary
Berry & Associates (United States) is a research organisation in Dexter, US. OpenAlex records 773 works and 116,396 citations for it. 166 researchers list it as their most recent affiliation.
How many works does Berry & Associates (United States) have?
ScholarIQindexed works
Berry & Associates (United States) has 773 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Berry & Associates (United States) have?
ScholarIQcitation count
Berry & Associates (United States) has 116,396 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Berry & Associates (United States)?
ScholarIQresearcher count
Berry & Associates (United States) has 166 researchers in the ScholarIQ index.
What is the average h-index at Berry & Associates (United States)?
ScholarIQavg h-index
Berry & Associates (United States) has an average h-index of 110 in OpenAlex.
What is the ROR of Berry & Associates (United States)?
ScholarIQror
The ROR for Berry & Associates (United States) is on the source record.
What is the OpenAlex record for Berry & Associates (United States)?
ScholarIQopenalex
The OpenAlex for Berry & Associates (United States) is on the source record.
Who are the most-cited researchers behind Berry & Associates (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Berry & Associates (United States)?
ScholarIQmost cited works
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford A. Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert B. Livingston, James N. Ingle, Edith A. Perez, John T. Carpenter, David D. Hurd, James F. Holland, Barbara L. Smith, Carolyn I. Sartor, Eleanor H. Leung, Jeffrey S. Abrams, Richard L. Schilsky, Hyman B. Muss, Larry Norton
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Kevin S. Hughes, Lauren A. Schnaper, Jennifer R. Bellon, Constance Cirrincione, Donald A. Berry, Beryl McCormick, Hyman B. Muss, Barbara L. Smith, Clifford A. Hudis, Eric P. Winer, William C. Wood
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald A. Berry, Kirby I. Bland, Patrick I. Borgen, Gary M. Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, R. V. P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann D. Thor, Donald L. Weaver, H. Samuel Wieand, Frederick L. Greene
Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer
Kevin S. Hughes, Lauren A. Schnaper, Donald A. Berry, Constance Cirrincione, Beryl McCormick, Brenda Shank, Judith Wheeler, Lorraine A. A. Champion, Thomas J. Smith, Barbara L. Smith, Charles M. Shapiro, Hyman B. Muss, Eric P. Winer, Clifford A. Hudis, William Wood, David J. Sugarbaker, I. Craig Henderson, Larry Norton
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
William M. Sikov, Donald A. Berry, Charles M. Perou, Baljit Singh, Constance Cirrincione, Sara M. Tolaney, Charles Kuzma, Timothy Pluard, George Somlo, Elisa Port, Mehra Golshan, Jennifer R. Bellon, Deborah Collyar, Olwen Hahn, Lisa A. Carey, Clifford A. Hudis, Eric P. Winer
How much of the research on Berry & Associates (United States) is open access?
ScholarIQopen access share
75%OPEN ACCESS